Frontpage » Tag » placebo

News tagged with placebo

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

Neuroscience created May 21, 2013 | popularity 4.9 / 5 (18) | comments 0 | with audio podcast report

Monoclonal antibody appears effective and safe in asthma Phase IIa trial

A novel approach to obstructing the runaway inflammatory response implicated in some types of asthma has shown promise in a Phase IIa clinical trial, according to U. S. researchers.

Diseases, Conditions, Syndromes created May 21, 2013 | popularity 5 / 5 (1) | comments 0

Diabetes drug tested in Parkinson's disease patients

Parkinson's disease (PD) is a degenerative neurological disorder marked by a progressive loss of motor control. Despite intensive research, there are currently no approved therapies that have been demonstrated to alter the ...

Parkinson's & Movement disorders created May 20, 2013 | popularity not rated yet | comments 0

FDA has safety concerns on Merck insomnia drug

Federal health regulators say an experimental insomnia drug from Merck can help patients fall asleep, but it also carries worrisome side effects, including daytime drowsiness and suicidal thinking.

Medications created May 20, 2013 | popularity not rated yet | comments 0

'Gap' for HIV vaccine efforts after latest setback

The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.

HIV & AIDS created May 19, 2013 | popularity 5 / 5 (1) | comments 0

Ketamine shows significant therapeutic benefit in people with treatment-resistant depression

Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the ...

Psychology & Psychiatry created May 19, 2013 | popularity 4.9 / 5 (7) | comments 1 | with audio podcast

World first clinical trial supports use of Kava to treat anxiety

(Medical Xpress)—A world-first completed clinical study by an Australian team has found Kava, a medicinal South Pacific plant, significantly reduced the symptoms of people suffering anxiety.

Psychology & Psychiatry created May 13, 2013 | popularity 5 / 5 (2) | comments 1

Palivizumab cuts number of days of wheezing in preemies

(HealthDay)—Many pre-term babies suffer recurrent episodes of wheezing. Now, researchers say a common infection is a likely culprit and they may be able to prevent the breathing problems.

Diseases, Conditions, Syndromes created May 09, 2013 | popularity not rated yet | comments 0 | with audio podcast

Ambrisentan not effective in idiopathic pulmonary fibrosis

(HealthDay)—The endothelin A receptor-selective antagonist ambrisentan is not effective for reducing the rate of idiopathic pulmonary fibrosis (IPF) progression, according to a study published in the May ...

Diseases, Conditions, Syndromes created May 07, 2013 | popularity not rated yet | comments 0

Drug shows some benefit for kids with autism

(HealthDay)—An experimental drug for autism did not improve levels of lethargy and social withdrawal in children who took it, but it did show some other benefits, a new study finds.

Autism spectrum disorders created May 02, 2013 | popularity 4 / 5 (1) | comments 0

Collagenase clostridium histolyticum OK in Peyronie's

(HealthDay)—For patients with Peyronie's disease, treatment with collagenase clostridium histolyticum (CCH) intralesional injections is efficacious and tolerable, according to research published online ...

Diseases, Conditions, Syndromes created Apr 26, 2013 | popularity not rated yet | comments 0

Drugs can cut breast cancer risk for some, task force finds

(HealthDay)—The drugs tamoxifen and raloxifene (Evista) could reduce the risk of breast cancer among women who are at high risk of developing the disease, a new report confirms.

Cancer created Apr 16, 2013 | popularity not rated yet | comments 0

Topical anesthetics effective for premature ejaculation

(HealthDay)—Topical anesthetic agents seem to be effective and are generally well tolerated for patients with premature ejaculation (PE), according to a review published in the April issue of Urology.

Diseases, Conditions, Syndromes created Apr 12, 2013 | popularity 5 / 5 (1) | comments 0

Study suggests dexmedetomidine before surgery reduced remifentanil-induced hyperalgesia

Surgical patients who demonstrated heightened pain sensitivity, or hyperalgesia, induced by high doses of a synthetic opioid had their symptoms alleviated by co-treatment with dexmedetomidine, according to new research. Study ...

Medications created Apr 12, 2013 | popularity not rated yet | comments 0

Risk of new-onset diabetes varies with different statins

(HealthDay)—Different types and doses of statins seem to correlate with distinct risks of developing new-onset diabetes mellitus (DM), according to a meta-analysis published in the April 15 issue of The Am ...

Cancer created Apr 11, 2013 | popularity not rated yet | comments 0

Placebo

A placebo is a sham medical intervention. In one common placebo procedure, a patient is given an inert sugar pill, told that it may improve his/her condition, but not told that it is in fact inert. Such an intervention may cause the patient to believe the treatment will change his/her condition; and this belief does indeed sometimes have a therapeutic effect, causing the patient's condition to improve. This phenomenon is known as the placebo effect.

Placebos are widely used in medicine, and the placebo effect is a pervasive phenomenon; in fact, it is part of the response to any active medication. However, the deceptive nature of the placebo creates tension between the Hippocratic Oath and the honesty of the doctor-patient relationship. The placebo effect points to the importance of perception and the brain's role in physical health.

Since the publication of Henry K. Beecher's The Powerful Placebo in 1955 the phenomenon has been considered to have clinically important effects. This view was notably challenged when in 2001 a systematic review of clinical trials concluded that there was no evidence of clinically important effects, except perhaps in the treatment of pain and continuous subjective outcomes. The article received a flurry of criticism, but the authors later published a Cochrane review with similar conclusions. Most studies have attributed the difference from baseline till the end of the trial to a placebo effect, but the reviewers examined studies which had both placebo and untreated groups in order to distinguish the placebo effect from the natural progression of the disease.

For more information about Placebo, read the full article at Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.

Related topics: patients , diabetes , women , clinical trials